Literature DB >> 22101998

Dietary treatment of epilepsy: rebirth of an ancient treatment.

Sergiusz Jóźwiak1, Eric H Kossoff, Katarzyna Kotulska-Jóźwiak.   

Abstract

Since its introduction in 1921, the ketogenic diet has been in continuous use for children with difficult-to-control epilepsy. After decades of relative disuse, it is now both extremely popular and well studied, with approximately two-thirds of children demonstrating significant seizure reduction after 6 months. It is being used for less intractable seizures in children as well as recently adults. Modifications that help improve tolerability include the medium chain triglyceride diet, modified Atkins diet, and low glycemic index treatment. Major side effects include acidosis, increased cholesterol, kidney stones, gastroesophageal reflux, and growth disturbance. However, these side effects are usually treatable and nowadays often even preventable. Future non-epilepsy indications such as Alzheimer disease, amyotrophic lateral sclerosis, autism, and brain tumors are under active investigation. This dietary treatment for epilepsy has undergone a rebirth. Its widespread use in Poland and Europe is a welcome additional treatment for those with drug-resistant epilepsy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22101998     DOI: 10.1016/s0028-3843(14)60108-0

Source DB:  PubMed          Journal:  Neurol Neurochir Pol        ISSN: 0028-3843            Impact factor:   1.621


  5 in total

1.  Lipid-enriched diet rescues lethality and slows down progression in a murine model of VCP-associated disease.

Authors:  Katrina J Llewellyn; Angèle Nalbandian; Kwang-Mook Jung; Christopher Nguyen; Agnesa Avanesian; Tahseen Mozaffar; Daniele Piomelli; Virginia E Kimonis
Journal:  Hum Mol Genet       Date:  2013-10-24       Impact factor: 6.150

2.  Preclinical testing of the ketogenic diet in fragile X mice.

Authors:  Pamela R Westmark; Alejandra Gutierrez; Aaron K Gholston; Taralyn M Wilmer; Cara J Westmark
Journal:  Neurochem Int       Date:  2020-01-17       Impact factor: 3.921

Review 3.  A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel.

Authors:  Richard E Frye; Daniel Rossignol; Manuel F Casanova; Gregory L Brown; Victoria Martin; Stephen Edelson; Robert Coben; Jeffrey Lewine; John C Slattery; Chrystal Lau; Paul Hardy; S Hossein Fatemi; Timothy D Folsom; Derrick Macfabe; James B Adams
Journal:  Front Public Health       Date:  2013-09-13

4.  A Fine Balance of Dietary Lipids Improves Pathology of a Murine Model of VCP-Associated Multisystem Proteinopathy.

Authors:  Katrina J Llewellyn; Naomi Walker; Christopher Nguyen; Baichang Tan; Lbachir BenMohamed; Virginia E Kimonis; Angèle Nalbandian
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

Review 5.  Potential therapeutic use of the ketogenic diet in autism spectrum disorders.

Authors:  Eleonora Napoli; Nadia Dueñas; Cecilia Giulivi
Journal:  Front Pediatr       Date:  2014-06-30       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.